La enhances IRES-mediated translation of laminin B1 during malignant epithelial to mesenchymal transition

The majority of transcripts that harbor an internal ribosome entry site (IRES) are involved in cancer development via corresponding proteins. A crucial event in tumor progression referred to as epithelial to mesenchymal transition (EMT) allows carcinoma cells to acquire invasive properties. The translational activation of the extracellular matrix component laminin B1 (LamB1) during EMT has been recently reported suggesting an IRES-mediated mechanism. In this study, the IRES activity of LamB1 was determined by independent bicistronic reporter assays. Strong evidences exclude an impact of cryptic promoter or splice sites on IRES-driven translation of LamB1. Furthermore, no other LamB1 mRNA species arising from alternative transcription start sites or polyadenylation signals were detected that account for its translational control. Mapping of the LamB1 5′-untranslated region (UTR) revealed the minimal LamB1 IRES motif between −293 and −1 upstream of the start codon. Notably, RNA affinity purification showed that the La protein interacts with the LamB1 IRES. This interaction and its regulation during EMT were confirmed by ribonucleoprotein immunoprecipitation. In addition, La was able to positively modulate LamB1 IRES translation. In summary, these data indicate that the LamB1 IRES is activated by binding to La which leads to translational upregulation during hepatocellular EMT.

[1]  N. Sonenberg,et al.  mRNAs containing extensive secondary structure in their 5′ non‐coding region translate efficiently in cells overexpressing initiation factor eIF‐4E. , 1992, The EMBO journal.

[2]  S. Ménard,et al.  Prognostic significance of the 67-kilodalton laminin receptor expression in human breast carcinomas. , 1993, Journal of the National Cancer Institute.

[3]  V. Castronovo,et al.  Enhancement of metastatic potential of murine and human melanoma cells by laminin receptor peptide G: attachment of cancer cells to subendothelial matrix as a pathway for hematogenous metastasis. , 1993, Journal of the National Cancer Institute.

[4]  J. Hubbell,et al.  Covalently immobilized laminin peptide Tyr-Ile-Gly-Ser-Arg (YIGSR) supports cell spreading and co-localization of the 67-kilodalton laminin receptor with alpha-actinin and vinculin. , 1993, The Journal of biological chemistry.

[5]  K. Sundqvist,et al.  Chemotaxis and haptotaxis of human malignant mesothelioma cells: effects of fibronectin, laminin, type IV collagen, and an autocrine motility factor-like substance. , 1993, Cancer research.

[6]  R. Timpl,et al.  The laminins. , 1994, Matrix biology : journal of the International Society for Matrix Biology.

[7]  P. Bedossa,et al.  Transforming growth factor—beta 1 (TGF‐β1) and TGF‐β1 receptors in normal, cirrhotic, and neoplastic human livers , 1995, Hepatology.

[8]  P. Bedossa,et al.  Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 1 receptors in normal, cirrhotic, and neoplastic human livers. , 1995, Hepatology.

[9]  K. Takenaka,et al.  Differential display and integrin alpha 6 messenger RNA overexpression in hepatocellular carcinoma , 1995, Hepatology.

[10]  L. Gudas,et al.  Murine Laminin B1 Gene Regulation during the Retinoic Acid- and Dibutyryl Cyclic AMP-induced Differentiation of Embryonic F9 Teratocarcinoma Stem Cells (*) , 1996, The Journal of Biological Chemistry.

[11]  E. Campo,et al.  OVEREXPRESSION OF THE 67‐kD LAMININ RECEPTOR CORRELATES WITH TUMOUR PROGRESSION IN HUMAN COLORECTAL CARCINOMA , 1996, The Journal of pathology.

[12]  H. Beug,et al.  TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. , 1996, Genes & development.

[13]  K. Yamamoto,et al.  Differential expression of laminin receptors in human hepatocellular carcinoma , 1998, Gut.

[14]  J. Sabina,et al.  Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. , 1999, Journal of molecular biology.

[15]  T. Chow,et al.  A new internal-ribosome-entry-site motif potentiates XIAP- mediated cytoprotection , 1999, Nature Cell Biology.

[16]  A E Willis,et al.  Analysis of the c-myc IRES; a potential role for cell-type specific trans-acting factors and the nuclear compartment. , 2000, Nucleic acids research.

[17]  R. Korneluk,et al.  Functional Characterization of the X-Linked Inhibitor of Apoptosis (XIAP) Internal Ribosome Entry Site Element: Role of La Autoantigen in XIAP Translation , 2000, Molecular and Cellular Biology.

[18]  Yoon Ki Kim,et al.  La autoantigen enhances translation of BiP mRNA. , 2001, Nucleic acids research.

[19]  A. M. Arias.  Epithelial Mesenchymal Interactions in Cancer and Development , 2001, Cell.

[20]  T. Cedervall,et al.  The La protein. , 2002, Annual review of biochemistry.

[21]  R. Schulte‐Hermann,et al.  Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness. , 2002, Journal of cell science.

[22]  Sung Gyoo Park,et al.  Proteome analysis of hepatocellular carcinoma. , 2002, Biochemical and biophysical research communications.

[23]  Christopher J. Lee,et al.  Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. , 2003, Nucleic acids research.

[24]  R. Korneluk,et al.  The Internal Ribosome Entry Site-Mediated Translation of Antiapoptotic Protein XIAP Is Modulated by the Heterogeneous Nuclear Ribonucleoproteins C1 and C2 , 2003, Molecular and Cellular Biology.

[25]  H. Bujard,et al.  Conditional tetracycline‐regulated expression of TGF‐β1 in liver of transgenic mice leads to reversible intermediary fibrosis , 2003, Hepatology.

[26]  R. Korneluk,et al.  Distinct Regulation of Internal Ribosome Entry Site-mediated Translation following Cellular Stress Is Mediated by Apoptotic Fragments of eIF4G Translation Initiation Factor Family Members eIF4GI and p97/DAP5/NAT1* , 2003, The Journal of Biological Chemistry.

[27]  M. Caligiuri,et al.  BCR/ABL activates mdm2 mRNA translation via the La antigen. , 2003, Cancer cell.

[28]  R. Schulte‐Hermann,et al.  Immortalized p19ARF null hepatocytes restore liver injury and generate hepatic progenitors after transplantation , 2004, Hepatology.

[29]  M. V. van Eden,et al.  Demonstrating internal ribosome entry sites in eukaryotic mRNAs using stringent RNA test procedures. , 2004, RNA.

[30]  D. Turner,et al.  Incorporating chemical modification constraints into a dynamic programming algorithm for prediction of RNA secondary structure. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Holcik.  Targeting translation for treatment of cancer--a novel role for IRES? , 2004, Current cancer drug targets.

[32]  Zhao-You Tang,et al.  Expression of the integrinα5 subunit and its mediated cell adhesion in hepatocellular carcinoma , 2005, Journal of Cancer Research and Clinical Oncology.

[33]  R. Schulte‐Hermann,et al.  Integration of Ras subeffector signaling in TGF-beta mediated late stage hepatocarcinogenesis. , 2005, Carcinogenesis.

[34]  J. Chung,et al.  67-kDa Laminin Receptor Promotes Internalization of Cytotoxic Necrotizing Factor 1-expressing Escherichia coli K1 into Human Brain Microvascular Endothelial Cells* , 2005, Journal of Biological Chemistry.

[35]  S. Baird,et al.  Spurious splicing within the XIAP 5' UTR occurs in the Rluc/Fluc but not the betagal/CAT bicistronic reporter system. , 2005, RNA.

[36]  M. Kay,et al.  The 37/67-Kilodalton Laminin Receptor Is a Receptor for Adeno-Associated Virus Serotypes 8, 2, 3, and 9 , 2006, Journal of Virology.

[37]  P. Lambin,et al.  Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control , 2006, The EMBO journal.

[38]  M. Brown,et al.  The La Autoantigen Is a Malignancy-Associated Cell Death Target That Is Induced by DNA-Damaging Drugs , 2007, Clinical Cancer Research.

[39]  M. Holcik,et al.  Subcellular relocalization of a trans-acting factor regulates XIAP IRES-dependent translation. , 2007, Molecular biology of the cell.

[40]  M. Petz,et al.  The leader region of Laminin B1 mRNA confers cap-independent translation , 2007, Nucleic acids research.

[41]  O. Larsson,et al.  Eukaryotic translation initiation factor 4E induced progression of primary human mammary epithelial cells along the cancer pathway is associated with targeted translational deregulation of oncogenic drivers and inhibitors. , 2007, Cancer research.

[42]  M. Mokrejs,et al.  Firefly luciferase gene contains a cryptic promoter. , 2008, RNA.

[43]  M. Caligiuri,et al.  Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis. , 2008, Blood.

[44]  C. Mayr,et al.  Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer Cells , 2009, Cell.

[45]  K. Sekiguchi,et al.  The C-terminal Region of Laminin β Chains Modulates the Integrin Binding Affinities of Laminins* , 2009, Journal of Biological Chemistry.

[46]  S. Bullock,et al.  Egalitarian is a selective RNA-binding protein linking mRNA localization signals to the dynein motor. , 2009, Genes & development.

[47]  N. Socci,et al.  Akt phosphorylation of La regulates specific mRNA translation in glial progenitors , 2009, Oncogene.

[48]  A. Willis,et al.  The role of IRES trans-acting factors in regulating translation initiation. , 2010, Biochemical Society transactions.

[49]  H. Will,et al.  The RNA-binding protein La contributes to cell proliferation and CCND1 expression , 2011, Oncogene.

[50]  A. Komar,et al.  Cellular IRES-mediated translation , 2011, Cell cycle.